We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Concerned AHRQ Comparative Studies Could Limit Rx Access
Industry Concerned AHRQ Comparative Studies Could Limit Rx Access
January 31, 2006
The Agency for Healthcare Research and Quality’s (AHRQ) initiative to recommend preferred treatment options for a variety of health conditions could limit access to some medical therapies, especially if AHRQ’s efforts focus unduly on costs, say pharmaceutical and device manufacturers.